New insights into the diagnosis and management of bone health in premature ovarian insufficiency.

Premature ovarian insufficiency bone mineral density dual-energy X-ray absorptiometry fractures muscle osteoporosis premature menopause

Journal

Climacteric : the journal of the International Menopause Society
ISSN: 1473-0804
Titre abrégé: Climacteric
Pays: England
ID NLM: 9810959

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 7 5 2021
medline: 11 3 2022
entrez: 6 5 2021
Statut: ppublish

Résumé

Premature ovarian insufficiency (POI), defined as a loss of ovarian function before the age of 40 years, is a life-changing diagnosis that has numerous long-term consequences. Musculoskeletal complications, including osteoporosis and fractures, are a key concern for women with POI. The risk of bone loss is influenced by the underlying etiology of POI, and the degree and duration of estrogen deficiency. A decline in muscle mass as a result of estrogen and androgen deficiency may contribute to skeletal fragility, but has not been examined in women with POI. This article aims to review musculoskeletal health in POI; summarize the traditional and novel modalities available to screen for skeletal fragility and muscle dysfunction; and provide updated evidence for available management strategies.

Identifiants

pubmed: 33955314
doi: 10.1080/13697137.2021.1917539
doi:

Substances chimiques

Estrogens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

481-490

Commentaires et corrections

Type : ErratumIn

Auteurs

H H Nguyen (HH)

Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.
Department of Endocrinology, Monash Health, Clayton, VIC, Australia.
Department of Endocrinology and Diabetes, Western Health, St. Albans, VIC, Australia.

F Milat (F)

Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.
Department of Endocrinology, Monash Health, Clayton, VIC, Australia.
Metabolic Bone Research Group, Hudson Institute of Medical Research, Clayton, VIC, Australia.

A J Vincent (AJ)

Department of Endocrinology, Monash Health, Clayton, VIC, Australia.
Monash Centre for Health Research and Implementation, Monash University, Clayton, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH